A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2017
At a glance
- Drugs RAD 140 (Primary)
- Indications Breast cancer
- Focus Adverse reactions; First in man
- Sponsors Radius Health Inc.
- 03 Aug 2017 According to a Radius Health media release, the US FDA has accepted an Investigational New Drug (IND) application for RAD-140 and the company expects to initiate this trial in the second half of 2017.
- 16 Mar 2017 Status changed from planning to not yet recruiting.
- 03 Nov 2016 According to a Radius Health Inc media release, this trial is expected to initiate in 2017.